Fundz

Jazz Pharmaceuticals and AbCellera Collaborate for Development of Next-Generation T-cell Engaging Antibodies.

Jun 17, 2026

Contract Type

partnership

DublinManufacturingBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharma

Description

Jazz Pharmaceuticals and AbCellera announced a partnership to discover and develop next-generation T-cell engaging multispecific antibodies. The collaboration includes $56 million upfront and potential milestone payments up to $792 million.

Company Information

Company

Jazz Pharmaceuticals plc

Location

Dublin, Dublin, Ireland

About

Jazz Pharmaceuticals plc is a global biopharmaceutical company dedicated to developing life-changing medicines for people with limited or no options. The company's diverse portfolio of transformative medicines extends across the areas of neuroscience, sleep, hematology/oncology, and other therapeutic areas.

Related People

Philip
Likely contact at this company
••••••••@••••••••

See Philip's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Jazz Pharmaceuticals plc's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

Jazz Pharmaceuticals plc signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.